Yüklüyor......

Reimbursement for bone loss prevention is different between women with breast cancer and men with prostate cancer: time for a revision

The hormone dependent breast and prostate cancers have in general a very good survival, due to the anti-hormonal treatment. A disadvantage of this treatment is the increased risk of osteoporosis and fractures. It is surprisingly to note that denosumab has the same impact on fracture reduction incide...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Facts Views Vis Obgyn
Yazar: Tjalma, W.A.A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Universa Press 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4788334/
https://ncbi.nlm.nih.gov/pubmed/26977268
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!